Tertile 1 (< 173 mmol/day) (n = 61) | Tertile 2 (173–229 mmol/day) (n = 59) | Tertile 3 (230–491 mmol/day) (n = 60) | |
---|---|---|---|
Median survival analysis time (years) [IQR] | 10.3 years [3.6–20.9] | 14.3 years [7.5–27.2] | 12.8 years [12.8–21.4] |
All-cause mortality | 54 | 46 | 50 |
total follow-up (1000 person years) | 1.00 | 1.27 | 1.04 |
Rate (per 1000 person years)2 | 54.16 (41.48, 70.71) | 36.29 (27.18, 48.45) | 48.10 (36.45, 63.46) |
Unadjusted HR | REF | 0.61 (0.41, 0.91) | 0.90 (0.62, 1.33) |
P value | REF | 0.014 | 0.609 |